BIXT Message Board Post 27501278 | Bioxytran Inc
home / stock / bixt / bixt message board
steffanhen570
()
Posted on: Sep/12/2023 21:22:48
One of the medical concerns Bioxytran, Inc. is addressing is hypoxia, a condition characterised by low oxygen levels in the body. Their novel ideas have the potential to transform how we treat a wide range of medical diseases, from hypoxia-related illnesses to other essential medical difficulties. Bioxytran, Inc. ($BIXT) represents more than just a financial potential for investors. It's an opportunity to be a part of a mission that could have a significant impact on healthcare. As they go on their trip, investors may discover not just possible gains but also the delight of contributing to medical research discoveries.
News, Short Squeeze, Breakout and More Instantly...
-
BXT-25 is expected to oxygenate the brain BOSTON, MASSACHUSETTS, June 27, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke and Alzheimer's disease, announced that Bioxtran’s...
-
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
-
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...